Our previous finding that a common genetic variant identified by a GWAS for bladder cancer risk was also associated with A3B expression and APOBEC mutagenesis1 nominated A3B as the primary mutagenic APOBEC in bladder tumors. Here, APOBEC3B is linked to urinary bladder carcinoma.